ARCHIVES

Roche Reports New Avastin Results As FDA Mulls Breast Cancer Indication.

This article is from The Cancer Letter archive.

Vol. 34 No. 06 | February 15, 2008

Download PDF Visit The Full Archive

Related Articles

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Linda Weiss, director of NCI Office of Cancer Centers, to Retire in March 2015

November 26, 2014

Choice Of Reconstruction Can Depend On Who Consults

October 29, 2010

Promising Areas Of Research Listed By NCAB Subcommittee

February 12, 1982

ONS Meeting Again With ASCO And AACR In San Francisco

April 28, 1989

Severe Shortages Of Many Cancer Drugs Affecting Practices

November 19, 2010